Target- |
Mechanism- |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.United States |
First Approval Date30 Sep 1955 |
/ Not yet recruitingPhase 1 维生素D口服溶液在维生素D缺乏人群的安全性、耐受性及药代动力学研究
[Translation] Safety, tolerability and pharmacokinetics of vitamin D oral solution in vitamin D-deficient populations
主要研究目的:评价维生素D缺乏人群单次空腹口服维生素D口服溶液的安全性和耐受性。
次要研究目的:评价维生素D缺乏人群单次空腹口服维生素D口服溶液的药代动力学特征。
[Translation] Primary study objective: To evaluate the safety and tolerability of a single fasting oral dose of vitamin D oral solution in vitamin D-deficient individuals.
Secondary study objective: To evaluate the pharmacokinetic profile of a single fasting oral dose of vitamin D oral solution in vitamin D-deficient individuals.
100 Clinical Results associated with Guangxi Minglei Weisheng Pharmaceutical Co., LTD
0 Patents (Medical) associated with Guangxi Minglei Weisheng Pharmaceutical Co., LTD
100 Deals associated with Guangxi Minglei Weisheng Pharmaceutical Co., LTD
100 Translational Medicine associated with Guangxi Minglei Weisheng Pharmaceutical Co., LTD